Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response

被引：59

作者：

Di Bella D. ^{[1
]}

Erzegovesi S. ^{[1
]}

Cavallini M.C. ^{[1
]}

Bellodi L. ^{[1
]}

机构：

[1] Fond. Ctr. San Raffaele Monte Tabor, San Raffaele Vita-Salute University, Department Neuropsychiatric Sciences, 20127 Milan

来源：

The Pharmacogenomics Journal | 2002年 / 2卷 / 3期

关键词：

Fluvoxamine; Pharmacogenetics; Serotonin; Serotonin reuptake inhibitors; Tic disorder;

D O I：

10.1038/sj.tpj.6500090

中图分类号：

学科分类号：

摘要：

Recently, a role for a functional polymorphism within the promoter region of the serotonin transporter gene (5-HTTLPR) in conferring susceptibility to Obsessive Compulsive Disorder (OCD) has been suggested. The aim of this study was to test the hypothesis that allelic variation of the 5-HTTLPR could be associated with OCD susceptibility or influence the drug response in OCD. One hundred and eighty-one OCD patients were recruited; 92 patients underwent a standardized treatment with fluvoxamine. No significant differences in allele/genotype distribution of the 5-HTTLPR were found between 191 controls and OCD. No differences in fluvoxamine response in the three genotypes groups in OCD were found, considering Yale-Brown Obsessive Compulsive Scale (YBOCS) total scores. Nevertheless, a significant time per genotype interaction was found for the YBOCS subtotal compulsion scores. Considering patients without tic disorder co-diagnosis, a significant time per genotype, interaction for both YBOCS total scores and compulsion scores was found.

引用

页码：176 / 181

页数：5

共 42 条

[1] Pauls D.L., Alsobrook J.P. II, Goodman W., Rasmussen S., Leckman J.F., A family study of obsessive-compulsive disorder, Am. J. Psychiatry, 152, pp. 76-84, (1995)
[2] Nestadt G., Samuels J., Riddle M., Bienvenu O.J. III, Lian K.Y., LaBuda M., Et al., A family study of obsessive-compulsive disorder, Arch. Gen. Psychiatry, 57, pp. 358-363, (2000)
[3] McGuffin P., Mawson D., Obsessive-compulsive neurosis: Two identical twin pairs, Br. J. Psychiatry, 137, pp. 285-287, (1980)
[4] Cavallini M.C., Pasquale L., Bellodi L., Smeraldi E., Comlex segregation analysis for obsessive compulsive disorder and related disorders, Am. J. Med. Genet, 88, pp. 38-43, (1999)
[5] Alsobrook J.P. II, Leckman J.F., Goodman W.K., Rasmussen S.A., Pauls D.L., Segregation analysis of obsessive-compulsive disorder using symptombased factor scores, Am. J. Med. Genet, 88, pp. 669-675, (1999)
[6] Nestadt G., Lan T., Samuels J., Riddle M., Bienvenu O.J. III, Liang K.Y., Et al., Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex, Am. J. Hum. Genet, 67, pp. 1611-1616, (2000)
[7] Altemus M., Murphy D.L., Greenberg B., Lesch K.P., Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder, Am. J. Med. Genet, 67, pp. 409-411, (1996)
[8] Cavallini M.C., Di Bella D., Pasquale L., Henin M., Bellodi L., 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder, Psychiatry Res, 77, pp. 97-104, (1998)
[9] Billett E.A., Richter M.A., King N., Heils A., Lesch K.P., Kennedy J.L., Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene, Mol. Psychiatry, 2, pp. 403-406, (1997)
[10] McDougle C.J., Epperson C.N., Price L.H., Gelernter J., Evidence for linkage disequilibrium between serotonin tranporter protein gene (SLC6A4) and obsessive compulsive disorder, Mol. Psychiatry, 3, pp. 270-273, (1998)

← 1 2 3 4 5 →